The Parliamentary Committee on Health and Family Welfare has recommended that the Union Health Ministry audit the deaths of these people along with the states COVID-19 To ensure fair compensation to the patients, and the families of the victims due to lack of oxygen, especially during the second wave of the pandemic.
The panel submitted its report on Monday after analyzing various aspects of pandemic management including oxygen shortage, surveillance and vaccine development and administration.
In the report, the committee has also urged the government to raise its voice to identify the origin of Sars-CoV-2. The report said, “The committee, therefore, strongly recommends the government to consider its diplomacy by appealing to the community of nations to conduct further studies to identify the origin of COVID-19 and the culprits.” punish him on the international stage.”
lack of oxygen
“There were no definite guidelines for identification of deaths due to insufficient supply of oxygen. Lack of oxygen has not been recorded as the cause of death in the medical records and most of the deaths were attributed to co-morbidities,” the committee said in its report.
The committee said that on the request of the central government regarding the deaths due to lack of oxygen, 20 states responded, but none of them confirmed. “The committee is troubled by the unfortunate denial of the Ministry of Health and Family Welfare regarding the death of Kovid due to lack of oxygen in the country,” the report said.
It said the government had been warned of a possible shortage of oxygen in 2020, when it assured that the country was self-sufficient in oxygen. “The government failed to manage equitable distribution of oxygen among states and amid skyrocketing demand, the government could not maintain a steady flow of oxygen, leading to an unprecedented medical crisis,” the report said.
The ministry informed the committee that the daily liquid medical oxygen supply was increased from 1,292 MT per day in February 2021 to 6,593 MT in April 2021. On May 28, 10,250 metric tonnes of LMOs were allocated to the states. The government also said that 1.02 lakh oxygen cylinders were procured in April and May 2020 and another 1.27 lakh cylinders were ordered in April 2021.
The committee also questioned the government’s decision on emergency use authorization for vaccines without any specific provision in the Clinical Trials Rules-2019 or the Drugs and Cosmetics Act, 1940. “The ambiguity on the procedure to be followed for the EU as well as for vaccine trials reflects the need to amend Indian laws,” the report said.
The committee also suggested that a rigorous evaluation should be done before granting such approvals in future. It also recommended research into optimizing the interval between vaccine doses. It also suggested smaller vaccine vials of five doses each to prevent wastage.
The committee also questioned India not giving up intellectual property rights. covaxin Which was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.
“…India has been advocating for exemption of intellectual property rights for COVID vaccines globally, however, the Committee is surprised that the government has not taken any major initiative to waive this for the indigenous vaccine, Covaxin, which has been developed in collaboration. With ICMR,” the report said, the possibility of technology transfer in public sector undertakings should be explored.